We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.
- Authors
Priddy, Frances H; Brown, Deborah; Kublin, James; Monahan, Kathleen; Wright, David P; Lalezari, Jacob; Santiago, Steven; Marmor, Michael; Lally, Michelle; Novak, Richard M; Brown, Stephen J; Kulkarni, Priya; Dubey, Sheri A; Kierstead, Lisa S; Casimiro, Danilo R; Mogg, Robin; DiNubile, Mark J; Shiver, John W; Leavitt, Randi Y; Robertson, Michael N; Mehrotra, Devan V; Quirk, Erin; Merck V520-016 Study Group
- Abstract
The safety and immunogenicity of the MRK adenovirus type 5 human immunodeficiency virus type 1 clade B gag/pol/nef vaccine, a replication-incompetent adenovirus type 5-vectored vaccine designed to elicit cell-mediated immunity against conserved human immunodeficiency virus proteins, was assessed in a phase 1 trial.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Vol 46, Issue 11, p1769
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/587993